NCCN Patient Guides for Cancer
NCCN Patient Guides for Cancer is a digital library of oncology treatment protocols and patient-friendly educational resources for iOS and Android.
The App DNA
What makes this app unique?
The resource removes the cognitive friction of interpreting complex clinical data, allowing patients to participate more effectively in their treatment decisions.
For Patients diagnosed with cancer and their support networks seeking to understand clinical treatment options.
What does it look like?
Key features
Digital library of cancer treatment protocols and clinical practice standards for patient reference.
Curated lists of questions and glossaries designed to facilitate communication between patients and care teams.
Visual aids explaining complex medical concepts and treatment options.
How much does it cost?
The app operates as a free, donor-funded resource with no monetization gates, prioritizing accessibility and brand authority.
Velocity
Dormant developmentplatform expansionShow more...
Development has ceased, with no updates released in the last 330 days. The app's last recorded activity was a minor update on Android in October 2025, while the iOS version has not seen a release in 438 days. There is no evidence of ongoing maintenance or feature development.
Who built it?
National Comprehensive Cancer Network®
3 apps tracked · Medical
NCCN Guidelines®
NCCN Reimbursement ResourceUser Sentiment
What do users think recently?
The recent review mood reads excited. Users appreciate medical guidelines written in accessible language help patients share information with their caregivers and family and oncology professionals frequently recommend the resource to newly diagnosed patients for its clear educational value.
How are ratings & reviews evolving?
What users say, by theme
- Medical guidelines written in accessible language help patients share information with their caregivers and family
- Oncology professionals frequently recommend the resource to newly diagnosed patients for its clear educational value
- General user feedback post-update indicates the experience is merely acceptable rather than highly functional
5 of 5 recent reviews analyzed · limited sample
Read the full review analysisCompetition
Competitive landscape for NCCN Patient Guides for Cancer
How's the Medical market?
NCCN Patient Guides for Cancer holds a 4.5-star rating across 36 total reviews, reflecting its established authority in the medical category. The lack of updates for over 330 days suggests the platform prioritizes content stability over feature-driven growth.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for NCCN Patient Guides for Cancer
Where is it heading?
The oncology education market is shifting toward interactive, patient-centric digital tools that offer daily utility. NCCN Patient Guides for Cancer remains a stable, trusted authority, but its lack of development cadence leaves it vulnerable to competitors that integrate tracking and communication features.
- The 330-day update gap indicates a maintenance-only posture, which limits the platform's ability to respond to shifting patient expectations for interactive digital health tools.
The SWOT
- Clinical authority establishes a brand barrier that institutional and foundation support sustains.
- Integrating interactive patient-tracking tools could increase daily utility beyond the initial diagnosis phase.
Next best moves
Audit current content for mobile-first readability because recent feedback describes the experience as merely acceptable → increase engagement
The counter-intuitive read
The app's lack of updates is a feature, not a bug…
Read the full takeBottom line
NCCN Patient Guides for Cancer maintains its position through clinical authority, but the lack of active development limits its ability to evolve with patient needs. Refreshing the core interface would sustain its relevance against more interactive health-tech entrants.
Unlock 1 critical friction, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] Play Store listing
Report last updated